Löffel Lukas M, Kleeb Bettina, Burkhard Fiona C, Wuethrich Patrick Y
Department of Anesthesiology and Pain Medicine, Inselspital, Bern University Hospital, CH-3010 Berne, Switzerland.
Trials. 2014 Jul 8;15:276. doi: 10.1186/1745-6215-15-276.
The optimal crystalloid solution to use perioperatively in patients undergoing open radical cystectomy remains unclear. Many of the fluids used for intravenous hydration contain supraphysiologic concentrations of chloride, which can induce hyperchloremia and metabolic acidosis, resulting in renal vasoconstriction and decreased renal function. In addition, patients receiving less fluid and less sodium show faster recovery of gastrointestinal (GI) function after colonic surgery.
This is an investigator-initiated, single-center, randomized, controlled, parallel group trial with assessor-blinded outcome assessment, in the Department of Urology, University Hospital Bern, Switzerland. The study will involve 44 patients with bladder cancer scheduled for radical cystectomy and urinary diversion. The primary outcome is the duration between the end of surgery and the return of the GI function (first defecation). Secondary outcomes are fluid balance (body weight difference postoperatively versus preoperatively) and the incidence of kidney function disorders according to the Risk-Injury-Failure-Loss-End Stage Renal Disease (RIFLE classification). An equal number of patients are allocated to receive Ringerfundin® solution or a glucose/potassium-based balanced crystalloid solution as baseline infusion during the entire time that intravenous administration of fluid is necessary during the perioperative period. The randomized crystalloid solution is infused at a rate of 1 ml/kg/h until the bladder has been removed, followed by 3 ml/kg/h until the end of surgery. Postoperative hydration is identical in both groups and consists of 1,500 ml of the randomized crystalloid solution per 24 hours. Postoperative patient care is identical in both groups; patients are allowed to drink clear fluids immediately after surgery, and liquid diet is started on postoperative day 1, as well as active mobilization and the use of chewing gum. Body weight is measured daily in the morning. Time of first flatus and first defecation are recorded.
This trial assesses the benefits and harms of two different balanced crystalloid solutions for perioperative fluid management in patients undergoing open radical cystectomy with urinary diversion, with regard to return of GI function and effects on postoperative renal function.
Current Controlled Trials ISRCTN32976792 (registered on November 21 2013).
对于接受开放性根治性膀胱切除术的患者,围手术期使用的最佳晶体溶液仍不明确。许多用于静脉补液的液体含有超生理浓度的氯离子,可诱发高氯血症和代谢性酸中毒,导致肾血管收缩和肾功能下降。此外,结肠手术后接受较少液体和较少钠的患者胃肠道(GI)功能恢复更快。
这是一项由研究者发起的、单中心、随机、对照、平行组试验,采用评估者盲法评估结果,在瑞士伯尔尼大学医院泌尿外科进行。该研究将纳入44例计划接受根治性膀胱切除术和尿流改道的膀胱癌患者。主要结局是手术结束至胃肠道功能恢复(首次排便)的持续时间。次要结局包括液体平衡(术后与术前体重差异)以及根据风险-损伤-衰竭-丧失-终末期肾病(RIFLE分类)的肾功能障碍发生率。在围手术期需要静脉补液的整个期间,将分配同等数量的患者接受林格芬定溶液或基于葡萄糖/钾的平衡晶体溶液作为基础输注液。随机分配的晶体溶液以1毫升/千克/小时的速度输注,直至膀胱切除,然后以3毫升/千克/小时的速度输注直至手术结束。两组术后补液相同,每24小时输注1500毫升随机分配的晶体溶液。两组术后患者护理相同;患者术后可立即饮用清澈液体,术后第1天开始流食,以及积极活动和使用口香糖。每天早晨测量体重。记录首次排气和首次排便时间。
本试验评估了两种不同的平衡晶体溶液在接受开放性根治性膀胱切除术并进行尿流改道的患者围手术期液体管理中的益处和危害,涉及胃肠道功能恢复及对术后肾功能的影响。
当前受控试验ISRCTN32976792(于2013年11月21日注册)。